Edition:
United States

Thermo Fisher Scientific Inc (TMO)

TMO on New York Consolidated

213.51USD
19 Jan 2018
Change (% chg)

$1.10 (+0.52%)
Prev Close
$212.41
Open
$213.95
Day's High
$214.57
Day's Low
$212.36
Volume
1,439,862
Avg. Vol
1,513,415
52-wk High
$214.57
52-wk Low
$140.00

Latest Key Developments (Source: Significant Developments)

Juno Therapeutics And Thermo Fisher Scientific Announce CAR T Manufacturing Partnership
Wednesday, 20 Dec 2017 08:00am EST 

Dec 20 (Reuters) - Juno Therapeutics Inc ::JUNO THERAPEUTICS AND THERMO FISHER SCIENTIFIC ANNOUNCE CAR T MANUFACTURING PARTNERSHIP.JUNO THERAPEUTICS - OBTAINED RIGHTS TO USE CTS DYNABEADS CD3/CD28 MAGNETIC BEADS FOR CLINICAL, COMMERCIAL MANUFACTURING PROCESSES FOR CAR T THERAPIES.JUNO THERAPEUTICS INC - NO OTHER TERMS FROM THIS TRANSACTION WERE DISCLOSED.  Full Article

Thermo Fisher Scientific Acquires Continuous Emission Monitoring Assets From Eptek Technology
Monday, 4 Dec 2017 09:00am EST 

Dec 4 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC ACQUIRES CONTINUOUS EMISSION MONITORING ASSETS FROM EPTEK TECHNOLOGY.THERMO FISHER SCIENTIFIC INC - TERMS OF TRANSACTION WERE NOT DISCLOSED.​.  Full Article

Evoke Pharma signs commercial agreement with Thermo Fisher Scientific
Thursday, 9 Nov 2017 08:30am EST 

Nov 9 (Reuters) - Evoke Pharma Inc ::Signs commercial agreement with Thermo Fisher Scientific.Announced selection of Patheon division of Thermo Fisher Scientific as commercial manufacturing partner for Gimoti​.Under five-year agreement, Thermo Fisher will manufacture Gimoti for Evoke's potential commercial efforts​.  Full Article

Thermo Fisher Scientific and Cellular Biomedicine announce partnership to develop manufacturing processes
Monday, 6 Nov 2017 07:19am EST 

Nov 6 (Reuters) - Cellular Biomedicine Group Inc :Thermo Fisher Scientific and Cellular Biomedicine Group announce strategic partnership to develop manufacturing processes.Cellular Biomedicine Group Inc - ‍partnership focuses on research and development of an automated cell therapy manufacturing system​.  Full Article

Thermo Fisher enters agreement with Blueprint Medicines​
Tuesday, 31 Oct 2017 07:00am EDT 

Oct 31 (Reuters) - Thermo Fisher Scientific Inc TMO.N:Thermo Fisher Scientific Inc - ‍ expanded development of Oncomine Dx Target Test by entering into an agreement with Blueprint Medicines Corporation​.Thermo Fisher Scientific - co will retain rights to commercialize test globally, to lead necessary filings to seek clearance from regulatory agencies.Thermo Fisher Scientific Inc - ‍agreement to develop and commercialize Oncomine Dx Target Test as a companion diagnostic for BLU-667​.  Full Article

Thermo Fisher Scientific reports Q3 Adj EPS of $2.31
Wednesday, 25 Oct 2017 06:00am EDT 

Oct 25 (Reuters) - Thermo Fisher Scientific Inc ::Q3 GAAP earnings per share $1.34; Q3 adjusted earnings per share $2.31.Q3 revenue up 14 percent to $5.1 billion.Raising revenue 2017 guidance to range of $20.50 billion to $20.66 billion, from $19.71 billion to $19.89 billion.Raising 2017 adjusted earnings per share guidance to range of $9.29 to $9.38, from $9.15 to $9.28.Q3 earnings per share view $2.25, revenue view $5.03 billion -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $9.35, revenue view $20.51 billion -- Thomson Reuters I/B/E/S.  Full Article

TETRAPHASE PHARMACEUTICALS APPOINTS KAM UNNINAYAR AS CFO
Monday, 16 Oct 2017 09:00am EDT 

Oct 16 (Reuters) - Tetraphase Pharmaceuticals Inc ::TETRAPHASE PHARMACEUTICALS APPOINTS KAM UNNINAYAR AS CHIEF FINANCIAL OFFICER.‍MOST RECENTLY, KAMALAM UNNINAYAR​ SPENT OVER 11 YEARS OVERSEEING FINANCE ORGANIZATIONS AT THERMO FISHER SCIENTIFIC.KAMALAM UNNINAYAR MOST RECENTLY SPENT OVER 11 YEARS OVERSEEING FINANCE ORGANIZATIONS AT THERMO FISHER SCIENTIFIC​.  Full Article

Patheon announces intent to voluntarily delist from the NYSE
Tuesday, 22 Aug 2017 04:45pm EDT 

Aug 22 (Reuters) - Patheon Nv :Patheon announces intent to voluntarily delist from the NYSE subject to and conditioned upon the initial expiration of the tender offer and acquisition of shares by Thermo Fisher.  Full Article

Appaloosa LP cuts share stake in GM, ups in Thermo Fisher
Monday, 14 Aug 2017 04:35pm EDT 

Aug 14 (Reuters) - Appaloosa LP : :Appaloosa LP says cuts share stake in General Motors to 1.9 million shares from 5.2 million shares - SEC filing‍​.Appaloosa LP says ups share stake in Thermo Fisher Scientific to 375,000 shares from 160,000 shares - SEC filing‍​.Appaloosa LP says ups share stake in United Rentals Inc by 64.2 percent to 1.2 million shares - SEC filing‍​.Appaloosa LP - Change in holdings are as of June 30, 2017 and compared with the previous quarter ended as of March 31, 2017 ​.  Full Article

Thermo Fisher Scientific prices an offering of $1.5 bln aggregate principal amount
Thursday, 10 Aug 2017 07:09pm EDT 

Aug 10 (Reuters) - Thermo Fisher Scientific Inc -:Thermo Fisher Scientific prices offering of senior notes.Priced an offering of $1.5 billion aggregate principal amount.Priced $750 million aggregate principal amount of 3.2% senior notes due 2027, at 99.263% of principal amount.Priced $750 million aggregate principal amount of 4.1% senior notes due 2047, at 98.825% of principal amount.  Full Article

Japan's TEPCO invests in UK blockchain company Electron

* Japanese utility Tokyo Electric Power Company Holdings (TEPCO) has invested an undisclosed sum in Electron, a British technology company which specialises in blockchain technology